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ABSTRACT
Design: Prospective cohort study.
Setting: Teaching paediatric hospitaldInstituto de
Medicina Integral Prof. Fernando Figueira (IMIP),
Recife, Northeast Brazil.
Participants: 378 of 536 infants admitted in paediatric
wards from April to October 2009 were daily assessed
during hospital stay until the ﬁrst episode of
nosocomial diarrhoea (ND), death or discharge.
Infants with community-acquired diarrhoea,
respiratory or haemodynamic instability and who
stayed in hospital for <24 h were excluded.
Primary and secondary outcome
measures: Incidence and risk factors for ND and rates
of paciﬁer faecal contamination.
Results: 33 ND episodes occurred in 378 infants, with
a cumulative incidence of 8.7% and density of 11.25/
1000 patients-day. ND occurred in 8.2% (16/194) of
paciﬁer users compared with 9.2% (17/184) in non-
users (adjusted OR¼0.88, 95% CI 0.43 to 1.80). In
multivariate logistic regression analysis, duration of
oxygen use (OR¼1.61; 95% CI 1.18 to 2.20) and days
of antimicrobial use (OR¼1.62, 95% CI 1.34 to 1.94)
were associated with higher risk of ND, whereas being
breast fed (OR¼0.40, 95% CI 0.17 to 0.93) and each
day of hospital stay (OR¼0.65, 95% CI 0.53 to 0.80)
were protective factors. Faecal coliforms were isolated
in 16% (27/169) of tested paciﬁers, 77.8% of which
had more than 100000 CFU/ml. The probability of
a child remaining free of an episode of diarrhoea up to
the seventh day of hospitalisation in the ward was
91.2% (95% CI 87.7% to 94.9%). The log-rank test
showed no statistical difference between paciﬁer users
and non-users.
Conclusions: ND is a frequent healthcare-associated
infection in paediatric wards, but the use of paciﬁers
during the stay in hospital does not seem to affect the
incidence of ND in infants in many settings where the
burden of diarrhoea is still high.
INTRODUCTION
Nosocomial diarrhoea (ND) in children is
associated with increased morbidity, mortality
and length and cost of hospital stay.
1 Low
adherence to hand washing facilitates person
to person spread of diarrhoea pathogens in
hospital settings, but indirect transmission
also plays a role. Potential sources of trans-
mission include water, food or contaminated
surfaces such as toys or bed linen, as well as
bottle and paciﬁer teats.
2 Despite controversy
surrounding the recommendation of paciﬁer
use, their use is very common in paediatric
wards.
3 Previous reports have investigated
paciﬁer use and the risk of diarrhoea in
community settings,
4 but we could ﬁnd no
well-designed studies looking into paciﬁer
use and hospital-acquired diarrhoea. This
report investigates the association of paciﬁer
use and the risk of ND in a cohort of children
from Recife, Brazil.
METHODS
This was a hospital-based prospective cohort
study of children aged >28 days and <2 years
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- Healthcare-associated infections in paediatric
hospital.
- ND incidence.
- Inﬂuence of paciﬁer use and ND in hospitalised
children.
Key messages
- Paciﬁer use is common in paediatric wards and
ND is a frequent healthcare-associated infection
in hospitalised infants.
- The use of paciﬁers during hospital stay does not
seem to affect the incidence of ND in infants in
a high diarrhoea burden setting. Breast feeding
reduces the incidence of ND in infants in a high
diarrhoea burden setting.
Strengths and limitations of this study
- The study did not assess microbial aetiology of
ND and, due to limited isolation facilities, infants
admitted with community-acquired diarrhoea
were not routinely segregated in this study
setting.
- To our knowledge, this is the ﬁrst report of
a hospital-based prospective cohort designed to
investigate the association of paciﬁer use and the
risk of ND in infants.
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Open Access Researchold who were admitted to the Instituto de Medicina
Integral Prof. Fernando Figueira (IMIP) in Recife,
Northeast Brazil. IMIP is a publically funded teaching
hospital that has three paediatric wards for children
<2 years old. Each ward has an area of 25 m
2 within
which nine cradles and nine chairs (for accompanying
parents). In each ward, there is a sink with constantly
supplied running chlorinated water, liquid soap and
disposable paper towels. For the healthcare workers,
disposable latex gloves are used for patient handling
during procedures when there is risk of exposure to
body ﬂuids. Children admitted to hospital for causes
other than diarrhoea were consecutively enrolled
between April and October 2009.
Accompanying parents or guardians were asked if
paciﬁers were brought to hospital and children were
observed daily. The use of any paciﬁer during the
hospital stay was the main exposure measure, while the
ﬁrst episode of ND was the main outcome measure.
Children presentingddiarrhoea after <72 h or who
were hospitalised for <24 h, those admitted for
community-acquired diarrhoea and those presenting
with haemodynamic or respiratory instability were
excluded.
ND was deﬁned as liquid stools for more than 12 h,
with or without fever or vomiting, and no likely
non-infectious cause that was acquired after 72 h of
admission.
1
The possible factors associated with nosocomial
infectious diarrhoea were as follows: socioeconomic
variables (per capita income of family, mother’s level of
education), sex and age (#6 months), nutritional status
(considering # 2 weight/age z-score WHO curve
2007),
5 low weight at birth (<2500 g), prematurity
(<37 weeks gestational age), breast feeding, ﬁnger
sucking habit, use of baby bottles and rotavirus vaccina-
tion status (Rotarix  GlaxoSmithKlineBiologicals
Laboratory, oral vaccine, attenuated monovalent (G1P
[8], strain RIX4414)). Other exposure factors investi-
gated during hospitalisation and before the occurrence
of the outcome or discharge were use of medication
(antibiotics, antiemetics, glucocorticoids, sedatives/
analgesics, H2 blockers), fasting (feeding withdrawn due
to gastric residues) and use of common invasive proce-
dures (central venous catheter, urinary catheter, gastric
tube, oxygen therapy by nasal catheter). The length of
stay (LOS) and the patient-days of use of medication or
devices were measured up to the occurrence of ﬁrst-
onset episode of diarrhoea, discharge from hospital or
death.
Data from the medical and nursing charts and those
from direct observation were recorded in a standardised
form by a research nurse and research assistant on
a daily basis until discharge. Changes in exposure
factors, clinical condition or diarrhoeal episodes were
recorded.
A sample size calculation was performed using EpiInfo
V.3.5.1. To inform power calculations, we did use local
ward survey data that found that a third of the mothers
of babies hospitalised in the weeks prior to study enrol-
ment reported paciﬁer use. Assuming a 9% frequency of
ND in non-exposed children, 354 children would be
required to detect a difference of 20% in the risk of
diarrhoea, with 80% statistical power and a 5% level of
signiﬁcance. To allow for possible losses, 378 children
were enrolled.
Data were entered in duplicate, and statistical analyses
were performed using STATA V.9.1. ORs were described
with 95% CIs and each variable was controlled for LOS.
Use of paciﬁers and variables associated with the risk of
diarrhoea at a level of p<0.2 in bivariate analysis were
selected for inclusion in the multivariate model. A
backward stepwise procedure was followed to obtain
adjusted OR in multivariate logistical regression. The R
software V.2.6.0 was used for survival analysis (The R
Foundation for Statistical Computing).
To assess colonisation by faecal coliforms, paciﬁer teats
were immersed in braineheart-infusion media. Speci-
mens were immediately taken to the hospital microbi-
ology laboratory and plated on to MacConkey and
Hektoen Enteric Agar (Himedia Laboratories, Mumbai,
India). Isolates with appropriate colonial morphology
were subcultured and conﬁrmed to be oxidase-negative
Gram-negative bacilli. TSI (Triple Sugar Iron Agar) and
SIM (Sulﬁde Indole Motility) tests were used to differ-
entiate Klebsiella spp. from other enteric bacilli according
to the Clinical and Laboratory Standards Institute
guidelines.
6
The study was approved by IMIP’s Research Ethics
Committee and all parents or guardians had signed
a consent form.
RESULTS
Throughout the study period, 378 of 536 infants fulﬁlled
the eligibility criteria. Fifty-six (10.4%) children with
community-acquired diarrhoea, 90 with either respira-
tory or haemodynamic instability; ﬁve who stayed in
hospital for <24 h were excluded. There were seven
losses (1.3%) due to failure to obtain informed consent.
The cohort of 378 infants was followed for a total of
2932 patient-days. There was a predominance of male
(59%), and the median age was 4.1 months (IQR
2e9.6 months). Children came from a low socioeco-
nomic status with median family income (monthly) per
capita of U$64.87 (IQR 32.49e93.23) and maternal
schooling of 9 years (IQR 7e12 years) among those with
ND and 8 years for those without diarrhoea (IQR
6e12 years). Fifty-ﬁve per cent (208/378) of children
were being breast fed (either exclusively or mixed) at the
time of admission to hospital. The median duration of
exclusive breast feeding was 2 months.
Thirty-three of the 378 infants developed ND (8.7%)
with an incidence density of 11.3 per 1.000 patient-days.
Table 1 shows the distribution of infants with and
without ND according to the factors reported at admis-
sion and observed during hospitalisation. Almost half of
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Do paciﬁers increase the risk of nosocomial diarrhoea? A cohort studythe infants (51.4%) enrolled at this cohort study (194/
378) used a paciﬁer during their stay in hospital. The
rate of paciﬁer use in breastfed babies was 65% (135/
208) and 35% for non-breastfed babies (59/170). Paci-
ﬁers users presented 8.2% (16/194) of hospital-acquired
diarrhoea compared with 9.2% (17/184) at non-users
(time adjusted bivariate analysis OR¼0.88, 95% CI 0.43
to 1.80). There were no differences between median
LOS for paciﬁer users (6 days, IQR 4e10 days) and non-
users (6 days, IQR 4e9 days). Twelve (3%) children died
during follow-up, two of whom had ND.
In multivariate logistic regression analysis (table 2),
risk and protective factors for nosocomial diarrhoea,
controlled for LOS, were duration of oxygen by nasal
catheter use (OR¼1.61, 95% CI 1.18 to 2.20), days of
antimicrobial use (OR¼1.62, 95% CI 1.34 to 1.94), being
breast fed during the hospitalisation (OR¼0.40, 95% CI
0.17 to 0.93), each day on hospital stay (OR¼0.65, 95%
CI 0.53 to 0.80) and paciﬁer user (OR¼1.03, 95% CI
0.43 to 2.47).
The likelihood of a child remaining free of ND for
each day of stay in the paediatric ward was estimated
using the KaplaneMeier method, and the curves for
paciﬁer users and non-users were drawn (ﬁgure 1). The
probability of a child remaining free of an episode of
diarrhoea up to the seventh day of hospitalisation in the
ward was 91.2% (95% CI 87.7% to 94.9%). The log-rank
test showed no statistical difference between paciﬁer
users and non-users.
One hundred and sixty-nine (87.1%) of 194 paciﬁers
were available for culture, 16 belonged to the infants
with diarrhoea and 153 for those without diarrhoea.
Faecal coliforms were isolated in 16% (27/169) of
samples. Among the infants with diarrhoea, in only one
Table 1 Frequency distribution and bivariate analysis of the association between intrinsic and extrinsic factors and the







OR (95% CI)* p Value N[378 n[33 n[345
n (%) n (%) n (%)
Intrinsic factors
Paciﬁer user in the hospital 194 (51.3) 16 (48.5) 178 (51.6) 0.88 (0.43 to 1.80) 0.72
Bottle feeding 281 (74.3) 21 (64.0) 260 (75.4) 0.57 (0.27 to 1.21) 0.15
Finger sucking habit 36 (9.5) 3 (9.0) 33 (9.6) 0.95 (0.27 to 1.32) 0.94
Rotavirus vaccination 173 (45.8) 16 (48.5) 157 (45.5) 0.87 (0.43 to 1.80) 0.73
Age #6 months 234 (62.0) 21 (64.0) 213 (61.7) 1.09 (0.52 to 2.29) 0.82
Sex, male 223 (59.0) 21 (64.0) 202 (58.5) 1.25 (0.59 to 2.62) 0.56
Low weight at birth 61 (16.1) 5 (15.1) 56 (16.2) 0.92 (0.34 to 2.48) 0.87
Prematurity 67 (17.7) 6 (18.2) 61 (17.7) 1.03 (0.41 to 2.61 0.94
Breast feeding 208 (55.0) 12 (36.4) 196 (56.8) 0.43 (0.20 to 0.90) 0.03
Nutritional status, weight/age
z-score # 2
56 (14.8) 6 (18.2) 50 (14.5) 1.3 (0.50 to 3.34) 0.59
Extrinsic factors
Use of devices or medication
Central venous catheter 31 (8.2) 6 (18.2) 25 (7.2) 2.96 (1.06 to 8.23) 0.04
Peripheral venous catheter 281 (74.3) 25 (75.8) 256 (74.2) 1.08 (0.47 to 2.49) 0.85
Gastric tube 86 (22.7) 12 (36.4) 74 (21.4) 2.1 (0.986 to 4.53) 0.06
Oxygen therapy by nasal catheter 48 (12.7) 6 (18.2) 42 (12.2) 1.59 (0.62 to 4.13) 0.34
Antibiotic 264 (69.8) 25 (75.8) 239 (69.3) 1.38 (0.60 to 3.16) 0.44
Corticoids 113 (29.9) 11 (33.3) 102 (29.7) 1.19 (0.55 to 2.54) 0.66
Gastric acid H2 blockers 54 (14.2) 6 (18.2) 48 (14.0) 1.36 (0.53 to 3.52) 0.52
Prolonged fasting 73 (19.3) 6 (18.2) 67 (19.4) 0.91 (0.36 to 2.30) 0.84
Median (IQR) Median (IQR) Median (IQR)
LOS, patient-daysy 266 (4e10) 6 (4e10) 6 (4e9) 1.00 (0.97 to 1.04) 0.83
Device utilisation, patient-days of usey
Central venous catheter 177 (0e0) 0 (0e0) 0 (0e0) 1.09 (0.97 to 1.23) 0.14
Peripheral venous catheter 856 (0e3) 2 (1e3) 2 (0e3) 0.98 (0.84 to 1.13) 0.76
Gastric tube 465 (0e0) 0 (0e2) 0 (0e0) 1.10 (0.98 to 1.22) 0.09
Oxygen therapy by nasal catheter 125 (0e0) 0 (0e0) 0 (0e0) 1.32 (1.04 to 1.68) 0.02
Antibiotic 1449 (0e6) 7 (1e11) 2 (0e6) 1.49 (1.28 to 1.74) 0.00
Corticoids 408 (0e1) 0 (0e1) 0 (0e1) 1.04 (0.92 to 1.18) 0.50
Gastric acid H2 blockers 344 (0e0) 0 (0e0) 0 (0e0) 1.03 (0.93 to 1.13) 0.61
Prolonged fasting 145 (0e0) 0 (0e0) 0 (0e0) 0.95 (0.71 to 1.28) 0.75
*OR adjusted for LOS to until ﬁrst-onset episode of diarrhoea, discharge or death. p values of less than 0.2 are shown in bold numbers.
yPatient-days until ﬁrst-onset episode of ND, discharge or death.
IMIP, Instituto de Medicina Integral Prof. Fernando Figueira; LOS, length of stay.
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Do paciﬁers increase the risk of nosocomial diarrhoea? A cohort studypaciﬁer was isolated a coliform (6.3%) and 16.0% within
those without diarrhoea (p¼0.47).
DISCUSSION
Despite the high costs and morbidity associated with ND,
the frequent use of paciﬁers by children admitted to
hospital and the potential of enteropathogens colo-
nising paciﬁers, this is, to our knowledge, the ﬁrst report
to prospectively assess the role of paciﬁers in ND. The
risk of ND in children between 29 days and <2 years of
age at IMIP paediatric wards during the 6-month
study period was not different in children who were
classiﬁed as paciﬁer users versus children who did not
use a paciﬁer.
Most infants in our cohort were paciﬁer user; however,
there was no statistically signiﬁcant association between
paciﬁer use and the occurrence of nosocomial diar-
rhoea. Described by the terms ‘paciﬁer’, and regionally
in northeastern Brazil as ‘comfort’, the use of paciﬁers
seems to be indicated in order to ‘pacify’ or ‘comfort’
the restless, especially suffering ill child.
7 8 Randomised
clinical study investigated the effect of non-nutritive
sucking (sucking of sterile water, sucrose or paciﬁer) as
an analgesic during invasive procedures and has been
shown that the use of a paciﬁer calms and modiﬁes pain
perception.
9
The lack of an association between paciﬁer use and
diarrhoea has been previously reported in a community
setting. Tomasi et al
4 performed a cross-sectional study in
poor neighbourhoods of Pelotas, Brazil, and found no
association between paciﬁer use and community-
acquired diarrhoea, even though faecal coliforms were
present in half of the tested paciﬁers. The authors
suggested that, in the highly contaminated environ-
ments where families from low socioeconomic back-
grounds live, the added risk of using paciﬁers would not
signiﬁcantly change the incidence of diarrhoea. This
may also be true for the baby cradle environment in
a busy and crowded hospital ward, where contamination
vectors are likely to include the hands of professionals
and associates, as well as food, water, utensils and
hospital supplies.
24
The protective effect of breast feeding in ND, observed
in this study (OR¼0.40, 95% CI 0.17 to 0.93, p¼0.03),
corroborates the evidence from the literature on the
protection of breast feeding in prevention of infections
especially diarrhoeal diseases in the community.
10e12
The ND was an adverse event that occurred in the ﬁrst
days of hospitalisation.
Arguably, the relative importance of contaminated
paciﬁers could be different in settings with lower inci-
dences of nosocomial gastrointestinal infection.
Accompanying persons stay with their children for most
of the time and it is not culturally acceptable to offer
a child someone else’s paciﬁer, we deem as small the risk
of an occasional unrecorded exposure. However,
circumstances similar to the present study site are often
found in many settings in low- and middle-income
countries, where the burden of diarrhoea is highest. The
present study suggests that, in isolation, measures to
restrict the use of paciﬁers in hospital are unlikely to
affect the incidence of ND in such settings. Health
professionals should thus focus on known effective
measures, such as hand washing, and look for factors
other than the use of paciﬁers in their efforts to prevent
spread of diarrhoeal pathogens in the hospital.
2 13 14
While the evidence-based beneﬁts and risks of paciﬁers
should inform the policies of healthcare facilities as
highlighted by the Unicef/WHO Baby-Friendly Hospital
Initiative, it should be remembered that there are still
controversial
3 15 potentially adverse effects arising from
the use of paciﬁers in early weaning of breastfeeding
infants.
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